NASDAQ: NXTS
Nexentis Technologies Inc Stock

$4.90-0.13 (-2.58%)
Updated Jun 10, 2026
NXTS Price
$4.90
Fair Value Price
N/A
Market Cap
$3.58M
52 Week Low
$3.38
52 Week High
$89.79
P/E
-0.22x
P/B
0.28x
P/S
-42.89x
PEG
N/A
Dividend Yield
N/A
Revenue
-$66.00k
Earnings
-$9.39M
Gross Margin
77.3%
Operating Margin
13,028.79%
Profit Margin
14,228.8%
Debt to Equity
0.27
Operating Cash Flow
-$4M
Beta
0.73
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

NXTS Overview

N2OFF, Inc. operates as a clean technology firm dedicated to pioneering sustainable energy solutions and advanced agricultural innovations. The company delivers integrated approaches for renewable energy generation, reducing greenhouse gas emissions, and enhancing safety and quality within the agri-tech sector. Its key offerings include SpuDefender, designed to manage post-harvest potato sprouting, and FreshProtect, which targets spoilage-inducing microorganisms on citrus fruits after harvesting. N2OFF structures its business around two primary divisions: pathogen prevention and shelf-life enhancement, and global warming solutions specifically addressing N2O emissions. Founded by Nimrod Ben-Yehuda on April 1, 2009, N2OFF is headquartered in Neve Yarak, Israel.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine NXTS's potential to beat the market

Zen Rating Component Grades

N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Agricultural Input

Industry Rating
B
NXTS
Ranked
Unranked of 11

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$5.50B
$116.51B
$109.26B
View Top Agricultural Input Stocks

Be the first to know about important NXTS news, forecast changes, insider trades & much more!

NXTS News

Overview

Due Diligence Score

Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NXTS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NXTS is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NXTS is good value based on its book value relative to its share price (0.28x), compared to the US Agricultural Inputs industry average (1.57x)
P/B vs Industry Valuation
NXTS is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more NXTS due diligence checks available for Premium users.

Valuation

NXTS fair value

Fair Value of NXTS stock based on Discounted Cash Flow (DCF)

Price
$4.90
Fair Value
$6.25
Undervalued by
21.57%
NXTS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NXTS price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.22x
Industry
33.58x
Market
14.77x

NXTS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.28x
Industry
1.57x
NXTS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NXTS's financial health

Profit margin

Revenue
$0.0
Net Income
-$6.6M
Profit Margin
0%
NXTS's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
NXTS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$16.4M
Liabilities
$3.5M
Debt to equity
0.27
NXTS's short-term assets ($8.22M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NXTS's short-term assets ($8.22M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NXTS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NXTS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.4M
Investing
-$450.0k
Financing
$2.2M
NXTS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NXTS vs Agricultural Input Stocks

TickerZen RatingMarket Cap1d %P/EP/B
NXTS$3.58M-2.58%-0.22x0.28x
SEED$11.92M+4.17%-0.98x-3.56x
BIOX$27.22M-1.61%N/A0.40x
AVDC$83.82M-2.01%-1.84x0.44x
IPIC$454.04M-2.31%31.59x0.91x

Nexentis Technologies Stock FAQ

What is Nexentis Technologies's quote symbol?

(NASDAQ: NXTS) Nexentis Technologies trades on the NASDAQ under the ticker symbol NXTS. Nexentis Technologies stock quotes can also be displayed as NASDAQ: NXTS.

If you're new to stock investing, here's how to buy Nexentis Technologies stock.

What is the 52 week high and low for Nexentis Technologies (NASDAQ: NXTS)?

(NASDAQ: NXTS) Nexentis Technologies's 52-week high was $89.79, and its 52-week low was $3.38. It is currently -94.54% from its 52-week high and 44.97% from its 52-week low.

How much is Nexentis Technologies stock worth today?

(NASDAQ: NXTS) Nexentis Technologies currently has 730,459 outstanding shares. With Nexentis Technologies stock trading at $4.90 per share, the total value of Nexentis Technologies stock (market capitalization) is $3.58M.

Nexentis Technologies stock was originally listed at a price of $60.76 in Oct 28, 2019. If you had invested in Nexentis Technologies stock at $60.76, your return over the last 6 years would have been -91.94%, for an annualized return of -34.27% (not including any dividends or dividend reinvestments).

How much is Nexentis Technologies's stock price per share?

(NASDAQ: NXTS) Nexentis Technologies stock price per share is $4.90 today (as of Jun 10, 2026).

What is Nexentis Technologies's Market Cap?

(NASDAQ: NXTS) Nexentis Technologies's market cap is $3.58M, as of Jun 11, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Nexentis Technologies's market cap is calculated by multiplying NXTS's current stock price of $4.90 by NXTS's total outstanding shares of 730,459.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.